Total Reports
240
FDA CVM filings
Dog /
FDA CVM · 2025 release 240 reports on file
Retriever - Nova Scotia Duck Tolling - FDA Adverse Event Profile
Adverse-event records for Retriever - Nova Scotia Duck Tolling (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
With 240 reports on file, Retriever - Nova Scotia Duck Tolling sits at #175 among dog breeds by volume; death-coded share is 1.7% (4 reports).
- #175
- most-reported dog breed
- 1.7%
- death-coded report share
- 65
- Vomiting - top reaction
- 5.8 yr
- average age at report
Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.
Deaths Reported
4
of 240 reports
Death Rate
1.7%
death-coded share
Avg Age at Report
5.8 yr
21.4 kg avg weight
Death-Coded Outcome Share
Retriever - Nova Scotia Duck Tolling death-coded reports 1.7%
Cross-breed median
1.7% of 240 retriever - nova scotia duck tolling reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 21.4 kg (47.2 lbs)
Top Reported Reactions
Vomiting 65
Lack of efficacy (endoparasite) - hookworm 20
Diarrhoea 17
Lethargy (see also Central nervous system depression in 'Neurological') 13
Lack of efficacy - NOS 13
Lack of efficacy (bacteria) - Borrelia 13
Lack of efficacy (ectoparasite) - tick NOS 12
Emesis 10
Most Referenced Drugs
Milbemycin Oxime + Spinosad 37
Ivermectin + Pyrantel As Pamoate Salt 35
Milbemycin Oxime + Praziquantel 21
Afoxolaner 20
Pyrantel Pamoate;Sarolaner 17
Fluralaner Chew Tablets 13
Grapiprant 10
Spinosad 8
Outcome Breakdown
Outcome Unknown
87 (38.3%)
Recovered/Normal
75 (33.0%)
Ongoing
53 (23.3%)
Recovered with Sequela
8 (3.5%)
Died
3 (1.3%)
Euthanized
1 (0.4%)
Gender Distribution
Female 126 (52.5%)
Male 106 (44.2%)
Mixed 5 (2.1%)
Unknown 3 (1.3%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2010 | 11 | |
| 2011 | 3 | |
| 2012 | 7 | |
| 2013 | 10 | |
| 2014 | 16 | |
| 2015 | 15 | |
| 2016 | 26 | |
| 2017 | 18 | |
| 2018 | 22 | |
| 2019 | 17 | |
| 2020 | 15 | |
| 2021 | 12 | |
| 2022 | 11 | |
| 2023 | 22 | |
| 2024 | 22 | |
| 2025 | 13 | |
Retriever - Nova Scotia Duck Tolling Pet Health Insights
Retriever - Nova Scotia Duck Tolling accounts for 240 FDA adverse event reports, ranking #175 by volume among dog breeds, with 4 reports (1.7%) coded as a death outcome. Mean age at report: 5.8 years, average weight 21.4 kg (47.2 lbs).
Top reported signs: Vomiting (65), Lack of efficacy (endoparasite) - hookworm (20), Diarrhoea (17). Most-referenced drug: Milbemycin Oxime + Spinosad (37 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (35) and Milbemycin Oxime + Praziquantel (21).
Outcome coding on 227 status-recorded reports is dominated by Outcome Unknown (38.3%). Annual submissions ranged 2,010-2,025 across 16 years on file.
Dog Breeds With a Similar Report Volume
Terrier - Norwich
232 reports · 3.0% death rate
Setter - Gordon
227 reports · 5.3% death rate
Spaniel - Tibetan
219 reports · 5.0% death rate
Griffon - French Wire-haired Pointing
218 reports · 0.5% death rate
Shepherd Dog - Dutch
262 reports · 1.1% death rate
Treeing Feist
215 reports · 1.9% death rate
Frequently Asked Questions
How many FDA adverse event reports involve Retriever - Nova Scotia Duck Tolling? ▼
There are 240 adverse event reports involving Retriever - Nova Scotia Duck Tolling in the FDA database, with 4 reports involving death (1.7% death rate). Retriever - Nova Scotia Duck Tolling ranks #175 by report volume.
What are the most common adverse reactions reported for Retriever - Nova Scotia Duck Tolling? ▼
The most commonly reported adverse reactions for Retriever - Nova Scotia Duck Tolling are Vomiting (65 reports), Lack of efficacy (endoparasite) - hookworm (20 reports), Diarrhoea (17 reports), Lethargy (see also Central nervous system depression in 'Neurological') (13 reports), Lack of efficacy - NOS (13 reports).
What drugs are most frequently associated with Retriever - Nova Scotia Duck Tolling adverse events? ▼
The drugs most frequently referenced in Retriever - Nova Scotia Duck Tolling adverse event reports are Milbemycin Oxime + Spinosad (37 reports), Ivermectin + Pyrantel As Pamoate Salt (35 reports), Milbemycin Oxime + Praziquantel (21 reports), Afoxolaner (20 reports), Pyrantel Pamoate;Sarolaner (17 reports).
What is the average age of Retriever - Nova Scotia Duck Tolling in adverse event reports? ▼
The average age of Retriever - Nova Scotia Duck Tolling at the time of adverse event reports is 5.8 years, with an average weight of 21.4 kg (47.2 lbs).
Does a high number of adverse event reports mean Retriever - Nova Scotia Duck Tolling is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Retriever - Nova Scotia Duck Tolling safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.